NCT06290947Completed
BFR Walking for Insulin and Aerobic Improvement in Type 2 Diabetes
Evaluating the Impact of Blood-Flow Restriction Walk Training on Insulin Sensitivity and Aerobic Capacity in Individuals With Type 2 Diabetes Mellitus: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 4 Mar 2024
Brief summary (registry, in English)
This clinical trial examines the impact of Blood-Flow Restriction Walk Training (BFRw) on insulin sensitivity and aerobic capacity in individuals with Type 2 Diabetes (T2D). The primary objectives of the study are to determine: If Blood-Flow Restriction Walk Training (BFRw) can improve insulin sensitivity in individuals with Type 2 Diabetes (T2D). Whether Blood-Flow Restriction Walk Training (BFRw) enhances aerobic capacity in individuals with Type 2 Diabetes (T2D). Participants in the study are divided into two groups. One group undergoes Blood-Flow Restriction Walk Training (BFRw), and the other serves as a control. Both groups attend three treadmill walking sessions weekly for eight weeks. The BFRw group has a restriction cuff placed around both thighs during their sessions, while the control group participates in the walking sessions without any blood flow restriction. Hemoglobin A1c (HbA1c) levels and maximal oxygen consumption (VO2 max) are monitored as indicators of insulin sensitivity and aerobic capacity, respectively.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 21 Feb 2024
- Start date
- 6 Mar 2022
- Primary completion date
- 20 Dec 2023
- Lead sponsor
- Arab American University (Palestine)
- Diseases
- Type 2 diabetes
- NCT number
- NCT06290947
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 6 Mar 2022 to the primary completion date, 20 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with conditions or comorbidities that impair walking or elevate the risk associated with Blood-Flow Restriction Training (BFRT).
- An Ankle Brachial Pressure Index (ABI) greater than 0.9, as values outside the normal range (0.9 to 1.4) may indicate Peripheral Arterial Disease (PAD) or Cardiovascular Disease (CVD), affecting eligibility for participation.
Age
- Individuals outside the 40-65 age range to minimize age-related variations in Diabetes Mellitus.
Other
- Females, due to hormonal and metabolic differences.
Who the study is looking for
- Male individuals of Palestinian descent
- Aged between 40 to 65 years
- Diagnosed with Type 2 Diabetes for a duration of 2 to 10 years, with ongoing medical supervision
- Capable of understanding and following the study's instructions, programs, and protocols
Age in the registry: 40 years to 65 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Arab American University - Palestine Coordinator of this site? Confirm its status | Jenin | Palestinian Territories | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.